LINZESS: payments to doctors
Payments that named LINZESS as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $15.1M
- Providers
- 66,122
- Transactions
- 593,539
- Average per transaction
- $25
The per-transaction average — $25 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 66,122 providers the average total is $228, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| AbbVie | $12,622,577 | 83.8% |
| Ironwood Pharmaceuticals, Inc | $2,431,247 | 16.2% |